Trice Medical Closes $19MM Financing

Trice Medical closed a $19.3MM Series C financing, including a minority stake from Smith & Nephew. Funds will support U.S. marketing for mi-eye2™, as well as ex-U.S. regulatory approvals. To date, Trice Medical has raised $40.9MM.

This second-gen iteration of the technology, which can be used in place of MRI to diagnose joint...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us